Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Merck nemtabrutinib discontinued infographic: three Phase 3 BELLWAVE CLL trials stopped
  • Pharmaceuticals
5 hours ago

Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review

Merck ended all development of its non-covalent BTK inhibitor nemtabrutinib after a monitoring committee flagged benefit-risk concerns in Phase 3 BELLWAVE-011. The trials, the reasons and what comes next.

  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening
  • CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
  • Lilly ObesityWeek 2026 Data: EloraTZP Hits 23% Weight Loss, Retatrutide Tackles Sleep Apnea
Isomorphic Labs Series C infographic: $5 billion round, $7.7 billion raised and AI drug discovery market growth
  • Industry Insights
6 hours ago

Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs

Isomorphic Labs raised $5 billion in biotech’s largest private round. Who invested, how the money will be used and why clinical proof is still missing.

  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable
Flagship Pioneering London lab infographic: £100M commitment and AI drug discovery market data
  • Industry Insights
22 hours ago

Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech

Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.

  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable
Leqembi five-year data infographic with CDR-SB benefit and ARIA figures
  • Pharmaceuticals
22 hours ago

Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

Five years of continuous lecanemab left patients 2.05 CDR-SB points better than an untreated cohort, while ARIA risk fell after year one. What the CTAD 2026 data mean for Eisai and Biogen.

  • Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review
  • CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
  • Lilly ObesityWeek 2026 Data: EloraTZP Hits 23% Weight Loss, Retatrutide Tackles Sleep Apnea
  • Pharmaceuticals

Tulisokibart Hidradenitis Suppurativa Trial Meets Endpoint

Megan Wood 5 hours ago
  • Industry Insights

Cell Line Development Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 5 hours ago
Merck nemtabrutinib discontinued infographic: three Phase 3 BELLWAVE CLL trials stopped
  • Pharmaceuticals

Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review

Megan Wood5 hours ago09 mins

Merck ended all development of its non-covalent BTK inhibitor nemtabrutinib after a monitoring committee flagged benefit-risk concerns in Phase 3 BELLWAVE-011. The trials, the reasons and what comes next.

Read More
Isomorphic Labs Series C infographic: $5 billion round, $7.7 billion raised and AI drug discovery market growth
  • Industry Insights

Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs

Megan Wood6 hours ago010 mins

Isomorphic Labs raised $5 billion in biotech’s largest private round. Who invested, how the money will be used and why clinical proof is still missing.

Read More
Flagship Pioneering London lab infographic: £100M commitment and AI drug discovery market data
  • Industry Insights

Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech

Megan Wood22 hours ago010 mins

Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.

Read More
Leqembi five-year data infographic with CDR-SB benefit and ARIA figures
  • Pharmaceuticals

Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

Megan Wood22 hours ago010 mins

Five years of continuous lecanemab left patients 2.05 CDR-SB points better than an untreated cohort, while ARIA risk fell after year one. What the CTAD 2026 data mean for Eisai and Biogen.

Read More
Illegal vape factory raid infographic with 850,000 vapes seized in Chino California
  • Industry Insights

Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California

Megan Wood1 day ago010 mins

A previously undisclosed raid on an illegal vape factory in Chino, California, recovered about 850,000 Geek Bar and Foger vapes and parts. What it means.

Read More
Seawolf Therapeutics infographic showing $100M funding and Sanofi deal worth up to $1.2 billion
  • Industry Insights

Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable

Megan Wood1 day ago010 mins

Seawolf Therapeutics debuts with $100M and a Sanofi pact worth up to $1.2B to develop non-viral DNA medicines for bleeding disorders. What TRIDENT promises and what is unproven.

Read More
Teva price-fixing settlement generic drugs infographic
  • Industry Insights

Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case

Megan Wood1 day ago010 mins

Teva has reached an agreement in principle with 45 states, DC and two territories over alleged generic drug price-fixing. Terms are undisclosed; here is what is known.

Read More
Gedeon Richter Mayne Pharma acquisition infographic with A$6.40 offer and 99.4% premium
  • Industry Insights

Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform

Megan Wood1 day ago010 mins

Gedeon Richter will pay A$6.40 a share, about A$604 million, for Mayne Pharma, a 99% premium that gives the Hungarian drugmaker a US women’s health business.

Read More
Lilly Stipple Bio deal infographic showing $5.9 billion milestones and ADC market data
  • Industry Insights

Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets

Megan Wood1 day ago1 day ago09 mins

Eli Lilly signed a multi-target oncology pact with Stipple Bio worth up to $5.9 billion in milestones. We break down the terms, the Pointillist platform and the ADC market it targets.

Read More
  • 1
  • 2
  • 3
  • …
  • 62

Categories

  • Healthcare IT (26)
  • Industry Insights (359)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (107)
  • Uncategorized (1)

Recent Posts

  • Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review
  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California

You May Have Missed

AAVantgarde AAVB-081 Usher syndrome and AAVB-039 Stargardt gene therapy data featured graphic
  • Pharmaceuticals

AAVantgarde Reports Updated Gene Therapy Data for Usher Syndrome and Stargardt Disease

Megan Wood 1 month ago1 month ago
Abbott to pay $495 million in damages in court ruling
  • Pharmaceuticals

Abbott to Pay $495 Million in Damages in a Shocking Court Ruling

Megan Wood 2 years ago2 years ago
Diabetic Neuropathy Treatment Market
  • Industry Insights

Diabetic Neuropathy Treatment Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 9 months ago
Poultry Vaccines Market Analysis, Trends, Dynamics, Regional Outlook, and Recent Developments
  • Industry Insights

Poultry Vaccines Market Analysis, Trends, Dynamics, Regional Outlook, and Recent Developments

Megan Wood 5 months ago
Graphic: hospital EBITDA impact shown as three bars with one reduced segment
  • Industry Insights

Hospital EBITDA Impact: India’s Cancer Drug Margin Cap

Megan Wood 4 weeks ago
Global healthcare AI regulatory network graphic: a shield with a medical cross for AI patient safety
  • Healthcare IT

Global Healthcare AI Regulatory Network Adds Poland: How AI Safety Alerts Work

Megan Wood 4 weeks ago4 weeks ago
Emcure Pharmaceuticals IPO recently opened on Indian stock market
  • Industry Insights

Emcure Pharmaceuticals IPO: Key Insights, Pros, and Cons for Investors in 2024

Megan Wood 2 years ago2 years ago
Osteoporosis Treatment Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Osteoporosis Treatment Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 6 months ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.